Clinical Trials Directory

Trials / Completed

CompletedNCT01756313

Optimizing Uptake of Methylaminolevulinat With Fractional Ablative Laser Technique

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
12 (actual)
Sponsor
Bispebjerg Hospital · Academic / Other
Sex
Male
Age
18 Years
Healthy volunteers
Accepted

Summary

The objectives of this study is to investigate if pre-treating the skin with an ablative fractional laser that creates small micropores in the skin: 1. Increases the uptake of Methylaminolevulinat (MAL) in the skin. 2. Decreases the required incubation time of MAL when performing photo dynamic therapy.

Detailed description

12 healthy male individuals were included. On the back, 25 areas measuring 2.8x2.8 cm were marked, plus one control area. We tested 2 variables. 1\) Density of laser channels. 2) Methylaminolevulinat (MAL) concentration 1. Laser - Each area was randomized to receiving: * no treatment * 1% laser channel density * 2% laser channel density * 5% laser channel density * 10% laser channel density * 15% laser channel density 2. MAL - Each density was assigned to 4 areas. Within each density category, the four areas were randomized to receive: * vehicle * 4% MAL * 8%MAL * 16%MAL The uptake of MAL was evaluated by fluorescence intensity measured with a florescence camera at t= * 0min * 30min * 1h * 1.5h 2h 2.5h 3h

Conditions

Interventions

TypeNameDescription
PROCEDURELaser+MethylaminolevulinatIt's a single arm study. Intervention as described in detailed description.

Timeline

Start date
2012-05-01
Primary completion
2012-08-01
Completion
2012-08-01
First posted
2012-12-25
Last updated
2015-07-28

Locations

1 site across 1 country: Denmark

Source: ClinicalTrials.gov record NCT01756313. Inclusion in this directory is not an endorsement.